Back to Search
Start Over
Complexing CpG adjuvants with cationic liposomes enhances vaccine-induced formation of liver T RM cells.
- Source :
-
Vaccine [Vaccine] 2023 Jan 27; Vol. 41 (5), pp. 1094-1107. Date of Electronic Publication: 2023 Jan 04. - Publication Year :
- 2023
-
Abstract
- Tissue resident memory T cells (T <subscript>RM</subscript> cells) can provide effective tissue surveillance and can respond rapidly to infection. Vaccination strategies aimed at generating T <subscript>RM</subscript> cells have shown promise against a range of pathogens. We have previously shown that the choice of adjuvant critically influences CD8 <superscript>+</superscript> T <subscript>RM</subscript> cell formation in the liver. However, the range of adjuvants tested was limited. Here, we assessed the ability of a broad range of adjuvants stimulating membrane (TLR4), endosomal (TLR3, TLR7 and TLR9) and cytosolic (cGAS, RIG-I) pathogen recognition receptors for their capacity to induce CD8 <superscript>+</superscript> T <subscript>RM</subscript> formation in a subunit vaccination model. We show that CpG oligodeoxynucleotides (ODN) remain the most efficient inducers of liver T <subscript>RM</subscript> cells among all adjuvants tested. Moreover, their combination with the cationic liposome DOTAP further enhances the potency, particularly of the class B ODN CpG 1668 and the human TLR9 ligand CpG 2006 (CpG 7909). This study informs the design of efficient liver T <subscript>RM</subscript> -based vaccines for their potential translation.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2022 Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1873-2518
- Volume :
- 41
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Vaccine
- Publication Type :
- Academic Journal
- Accession number :
- 36609029
- Full Text :
- https://doi.org/10.1016/j.vaccine.2022.12.047